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Abstract: A low-sodium diet is an essential part of the treatment of hypertension. However,
some concerns have been raised with regard to the possible reduction of iodine intake during salt
restriction. We obtained 24-h urine collections for the evaluation of iodine (UIE) and sodium excretion
(UNaV) from 136 hypertensive patients, before and after 9 ± 1 weeks of a simple low-sodium
diet. Body mass index (BMI), blood pressure (BP), and drug consumption (DDD) were recorded.
Data are average ± SEM. Age was 63.6 ± 1.09 year. BMI was 25.86 ± 0.40 kg/m2 before the diet
and 25.38 ± 0.37 kg/m2 after the diet (p < 0.05). UNaV decreased from 150.3 ± 4.01 mEq/24-h to
122.8 ± 3.92 mEq/24-h (p < 0.001); UIE decreased from 186.1 ± 7.95 µg/24-h to 175.0 ± 7.74 µg/24-h
(p = NS); both systolic and diastolic BP values decreased (by 6.15 ± 1.32 mmHg and by
3.75 ± 0.84 mmHg, respectively, p < 0.001); DDD decreased (∆DDD 0.29 ± 0.06, p < 0.05).
UNaV and UIE were related both before (r = 0.246, p = 0.0040) and after the diet (r = 0.238,
p = 0.0050). UNaV and UIE were significantly associated both before and after the diet (p < 0.0001 for
both). After salt restriction UIE showed a non-significant decrease remaining in an adequate range.
Our dietary suggestions were aimed at avoiding preserved foods, whereas the cautious use of table
salt was permitted, an approach which seems safe in terms of iodine intake.
Keywords: blood pressure; dietary sodium; hypertension; iodine; salt
1. Introduction
A low-salt diet constitutes a standard approach to the treatment of hypertensive patients [1–4].
Salt is the fundamental source of dietary sodium, an excess of which is linked to hypertension and
cardiovascular diseases [5–7]. While reducing excess dietary sodium is universally acknowledged to
be a favorable step in the reduction of cardiovascular risk [1–4], the recommendation of a low-sodium
approach in the general population is still controversial [8]. Recently, a J-shaped curve linking sodium
intake to cardiovascular events has been proposed [9,10], pointing to a possible risk induced by a
decreased sodium intake in the general population. However, these data have been disputed [11].
In Italy iodine supplementation was first undertaken in 1921 and iodized salt was introduced
by regulatory authorities in 1924 [12]. Since then, substantial progress has been made in the struggle
against iodine deficiency [13]. Nevertheless a mild insufficiency persists [14] and only recently
(Law n.55/2005) was a nationwide salt iodization program implemented [15].
The main concern raised by the reduction of sodium intake regards the possible deficiency of
iodine intake during a low-sodium diet [16]. In hypertensive patients in whom iodine status (IS) has
been evaluated by 24-h urinary iodine excretion (UIE) or by spot urine iodine concentration (UIC),
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or by anamnestic instruments such as 24-h dietary recalls or food frequency questionnaires (FFQ),
no general consensus has emerged [17,18]. This may partly stem from the different methods employed,
the greatest limitation being associated with anamnestic evaluation [19] and with the variability of
spot urine measurements versus the gold standard of UIE [20,21]. Another issue concerns the general
approach of studies in which sodium and iodine intake have been evaluated, in accordance with
an observational protocol, whereby it is assumed that patients displaying a reduction in urinary
sodium excretion are following a low-sodium diet, while those displaying no reduction are not [22,23].
Few intervention studies have shown adequate levels of iodine intake after salt restrictions [24,25].
An additional problem arises from the type of population examined. As a general rule, when an
iodine-sufficient population is studied, patients on a low-sodium diet show reduced UIC/UIE, but no
substantial change in IS [26]. When iodine-deficient patients follow a low-sodium diet, IS worsens [17,27].
In Italy, these concerns have already been raised [28]. Iodine deficiency leads to endemic goiter
and cretinism, because iodine is essential for the synthesis of thyroid hormones. In our country public
committees were appointed since the first half of the XIX century, for the identification of areas of
endemic goiter and endemic cretinism, mostly in the north-western and insular areas [15]. Since then,
many epidemiological evidences showed that iodine deficiency is present in mountain as well as in
coastal regions [15]. Although our district, the Liguria Region, is situated in a country of mild iodine
deficiency, it has recently become iodine-sufficient [29].
The aim of the present study was to evaluate the modification of UIE induced by a proposed
low-sodium diet in hypertensive patients. Urinary iodine excretion and 24-h urinary sodium excretion
(UNaV) were measured by standard methods before and after the administration of a dietary protocol.
2. Materials and Methods
In a larger cohort of 291 hypertensive patients [30], we obtained a 24-h urine collection (above at
least 700 mL) from 157 patients for UIE and UNaV evaluation (basal value: time t0), together with BMI
and blood pressure (BP) measurements. A low-sodium diet was then proposed. After 9 ± 1 weeks
(mean ± SD) we repeated the 24-h urine collection (time t2), BMI recording, and BP measurements.
The low-sodium diet prescribed by a dietitian was based on simple recommendations printed on
a single A4 sheet of paper [30]. Patients were advised to avoid salty foods, ice-cream, cheese, and cured
meats, such as bacon, ham, sausages, and so on. Low-sodium bottled water was recommended.
The patients were also asked to switch from regular bread to salt-free bread, which is commonly
available in Italy. Table salt itself was not banned, although limited use was suggested [30].
Twenty-four hour urines were collected in accordance with a standard protocol: after the first
morning void (to be discarded) patients were requested to record the time and to collect every
subsequent void until the same time the following day, when they had to collect the content of
the last void. All patients received written and verbal instructions, together with the appropriate
urine containers.
Blood pressure was measured by means of a semi-automated repeated-measures method (HEM
907 BP monitor, OMRON, Kyoto, Japan) as previously described [30] both at t0 and at t2. Blood pressure
was measured three times at each visit and the last value (BP3) was considered for analysis. Body weight
and BMI were obtained both at t0 and at t2. Anti-hypertensive drugs (as defined daily doses-DDD
following the WHO definitions) [31] were recorded both at t0 and at t2. Halfway between the two
visits, patients were suggested to have their BP evaluated by their general practitioner (who was aware
of the study but blind to the results), which adjusted their drug treatment, if necessary [30].
UNaV was measured by an AutoAnalyzer (COBAS 8000 Roche/Hitachi with an ISE module;
Roche Diagnostics, Indianapolis, IN, USA), while urinary iodine was measured by means of a current
commercial colorimetric method (Celltech, Turin, Italy) all CVs are below 8%.
All patients were on anti-hypertensive drug treatment. Patients on thyroid hormones, amiodarone
or with a recent history of contrast-media exposure were excluded. Patients unable or unwilling
to provide two (t0 and t2) 24-h urine collections (i.e., those with less than 700 mL of urines
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and/or violation of void collection), or with concomitant diseases such as congestive heart failure,
atrial fibrillation, renal failure, diabetes, electrolyte abnormalities, secondary hypertension, or goiter
were deemed ineligible.
Finally, 136 patients, who had successfully provided 24-h urine collections twice in a two months
period, were selected. Neither FFQ nor 24-h dietary recalls were used. The study population consisted
of Caucasian Europeans, 98%, and Latin Americans, 2%. Of the 136 patients, 84 (61.76%) claimed
to use iodized table salt routinely, in agreement with our national data [15]. All subjects gave their
informed consent for inclusion before they participated in the study. The study was conducted in
accordance with the Declaration of Helsinki, and the protocol was approved by the Ethics Committee
of our Hospital.
Statistics
Statistical analysis was performed using a commercial software package: PRISM 7.0 (Graph
Pad Software, La Jolla, CA, USA). Paired Student’s t-test, non-parametric analysis (Mann-Whitney,
or t-test with Welch correction, followed by F-test to compare variances), repeated-measures ANOVA
followed by multiple-comparison Newman-Keuls post-test, Kruskal-Wallis test (with Dunn’s multiple
comparison test), one-way ANOVA followed by Bartlett’s test for equal variances, linear regression
analysis, Fisher’s exact test and Chi-square test were carried out. The significance cut-off was set
at p < 0.05.
3. Results
Data are reported throughout as average ± SEM unless otherwise stated.
Patients were 83 females and 53 males. Their mean age was 63.6 ± 1.09 year.
Our intervention consisted of proposing a simple low-sodium protocol. The time-span between the
administration of the dietary protocol (visit at time t0) and the final visit (time t2) was 9 ± 0.12 weeks:
• BMI was 25.86 ± 0.40 kg/m2 before the dietary suggestions (visit t0) and 25.38 ± 0.37 kg/m2
afterwards (visit t2) (t-test and repeated-measures ANOVA and Newman-Keuls post-test, p < 0.05).
• UNaV decreased from 150.3 ± 4.01 mEq/24-h at visit t0 to 122.8 ± 3.92 mEq/24-h at visit t2
(repeated-measures ANOVA and post-test, p < 0.001).
• Both systolic and diastolic BP values decreased significantly from visit t0 to visit t2 (by
6.15± 1.32 mmHg and by 3.75± 0.94 mmHg, respectively. ANOVA and post-test, p < 0.001) (Figure 1).
• Drug consumption also decreased from visit t0 to visit t2 (∆DDD 0.29 ± 0.06, t-test, p < 0.05).
• Median UIE global values were 184.2 µg/24-h (lower and upper 95% CI 170.3 and 201.9) at t0,
and 162.0 µg/24-h (lower and upper 95% CI 159.6 and 190.3) at t2.
• Median UIE values in females were 178.2 µg/24-h (lower and upper 95% CI 163.0 and 204.3) at t0,
and 153.7 µg/24-h (lower and upper 95% CI 151.3 and 188.5) at t2.
• Median UIE values in males were 188.0 µg/24-h (lower and upper 95% CI 164.9 and 215.2)
at t0, and 170.0 µg/24-h (lower and upper 95% CI 155.9 and 210.5) at t2. One way ANOVA
(F = 0.6105, R square 0.006788) showed non-significant differences between UIE values in males vs.
females both before and after the diet period (p = 0.6087). Bartlett’s test for equal variances gave
non-significant results (Bartlett’s statistics 1.449, p = 0.6940, Newman-Keuls multiple comparison
test p > 0.05).
• UIE was below 100 µg/24-h in 28 patients before the suggested diet, and in 28 patients thereafter
(Fisher’s exact test: p = NS; Chi-square, df: 0.0, 1; p = NS).
• UIE decreased from 186.1 ± 7.95 µg/24-h at visit t0, to 175.0 ± 7.74 µg/24-h at visit t2
(repeated-measures ANOVA and post-test, p = NS). Furthermore, these data were reanalyzed with
non-parametric tests (Mann-Whitney, or Welch correction, t = 1.002, df = 269, 95% C.I. −10.67 to
+32.97), to avoid distributional assumptions (again, differences were non-significant: p = 0.2737 to
p = 0.3173). A possible UIE variability induced by the dietary suggestions was challenged with an
Nutrients 2018, 10, 1548 4 of 8
F test to compare variances before and after the observation period. F test showed non-significant
differences (F, DFn, Dfd, 1057, 135, 135; p = 0.7484).
• Significant relationships were found between UNaV and UI both before the administration of
the protocol, at visit t0 (r = 0.246, p = 0.004) (Figure 2) and after, at visit t2 (r = 0.238, p = 0.005)
(Figure 3).
• UNaV and UIE were significantly associated both before and after the dietary suggestions
(Chi-square test; df at t0 75.55, 1; df at t2 205.6, 1; p < 0.0001 for both).
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4. Discus ion
The proposed low-sodium diet induced a sig ificant reductio in UNaV, BMI, BP, and DDD in
our patients. Urinary iodine excretion showed a small, non-significant decrease.
We did not monitor the actual diet in our patients, because of the inherent limits of FFQ and 24-h
recall methods [19]. Instead, we relied on the UNaV, which is usually considered the gold standard for
the assessment of the sodium content of a diet [19]. Similarly, we relied on the UIE as a reference index
of iodine intake [20,21].
In our patients we did not evaluate urinary creatinine excretion, which is of limited value as a
measure of the completeness of 24-h collecti n [32,33], bec use of the high var ability of creatinine in
urine, w th a reported SD as high as 29 to 79% of the mean [32,34], with sensitivity and specificity for
identifying incomplete collections as low as 6% and 57%, respectively [35]. Instead, we relied on the
total 24-h urine volumes, with a high cut-off of 700 mL [30].
In our patients, the decrease in UNaV after the dietary suggestions was paralleled by significant
improvements in BMI and BP values, with an additional significant decrease in drug consumption.
Our patients seemed to follow our suggestions, apparently reducing their sodium intake from
(150.3 mEq × 23 =) 3.46 g/day, which is equivalent to 8.78 g/day of salt, to (122.8 mEq × 23 =) 2.82
g/day, which is equivalent to 7.17 g/day of salt. This small but significant decrease, albeit lower than
that suggested in the Guidelines [1–4], yiel ed a significant improvement in our pati nts’ BP values
(even more important in light of t eir reduced drug intake), once again displaying the favorable effect
of a low-sodium approach to arterial pressure control.
This effective UNaV reduction did not appear to affect UIE, which showed a non-significant
reduction from 186.1 to 175.0 µg/24-h. The approximate iodine intake thus decreased from (186.1/0.92
=) 202.3 µg/day, to (175.0/0.92 =) 190.2 µg/day [25,36].
The number of iodine-deficient patients (UIE below 100 µg/24-h) did not change from the basal
observation to the final visit (28/136 to 28/136, i.e., 20.59%).
Our data agree with previously published findings, which indicate that reduci g sodium
consumption in n iodin -sufficient population does not compromise iodine intake [26]. I our
hypert nsive patient , a successful intervention (in the form of dietary salt intake suggestions) was
followed by favorable effects in terms of UNaV, BMI, and BP reduction (even with a reduction in the
need for drugs).
Our instructions do not appear to induce a substantial nor significant decrease in iodine intake,
and the number of iodine-deficient subjects did not change substantially, nor significantly (actually,
it did not change at all). Differences between females and males were non-significant.
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In Italy, the primary source of salt is not processed or canned food (the use of which remains
negligible), nor the amount of salt added at the table or during cooking; rather, it is constituted by
three categories of food: bread, cheese, and cured meats [37]. The aim of our dietary suggestions
was to reduce sodium intake, while minimizing the iodine decrease. On our market, sales of iodized
table salt have risen to a current level of the 60% [15]. Although our district, the Liguria Region,
has recently achieved iodine sufficiency, Italy (as noted in the Introduction) suffers from mild iodine
deficiency [29]. This situation is reflected in our data, which showed average iodine sufficiency
(average UIE 186.1 µg/24-h, median UIE 184.2 µg/24-h; lower and upper 95% CI 170.3 and 201.9
before the dietary suggestions), but with 20% of iodine-deficient subjects (UIE < 100 µg/24-h). Efforts
to reduce salt intake in our country must take this fragile IS into account. This is why our suggestions
were aimed at reducing the main sources of salt (bread, cheese, and cured meats), whereas table salt
was not banned; we therefore managed not to cut a possible main source of iodine.
The fact that UNaV and UIE were significantly related and associated, both before and after the
administration of the diet protocol, suggests a possible common source of both sodium and iodine;
given that the three salty foods had been excluded from the dietary protocol, this common source was
presumably table salt. Our results support this view: the non-significant decrease in UIE seen in our
patients seems to fit in with the current low use of iodized salt (3–8%) by the Italian food industry [28],
with the implication that table salt remains the main source of iodine in our country [28].
5. Conclusions
In an area of iodine sufficiency, albeit in a mild iodine-deficient country, where table salt is the
main source of iodine, a low-sodium approach which primarily limits the salty foods (instead of a “no
salt added” suggestion) seems safe in terms of iodine intake, and does not worsen the IS.
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